Wesley Moore
Family Medicine · Hodgenville, KYNPI 1053792069
Payments from drug & device makers
Across 187 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$525
- Lilly USA, LLC$385
- Pfizer$332
- Novo Nordisk$234
- Medtronic$231
- Shield Therapeutics Inc$119
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,128100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $525 |
| Lilly USA, LLC | 26 | $385 |
| Pfizer | 18 | $332 |
| Novo Nordisk | 16 | $234 |
| Medtronic | 5 | $231 |
| Shield Therapeutics Inc | 5 | $119 |
| AstraZeneca | 8 | $110 |
| Corcept Therapeutics | 6 | $103 |
| GSK | 6 | $99 |
| Amgen | 6 | $99 |
| Astellas Pharma US Inc | 6 | $95 |
| Biohaven Pharmaceuticals, Inc. | 6 | $95 |
| Bayer | 5 | $87 |
| Novartis | 5 | $82 |
| Abbott | 5 | $78 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Henry Schein, Inc. | 1 | $49 |
| Merck | 3 | $47 |
| Tolmar, Inc. | 3 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Exact Sciences | 2 | $34 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Insulet Corporation | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Corium, LLC | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$155
How this compares
$3,128 in reported general payments places this provider in the 75th percentile of 1,559 family medicine providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 164 | $132,908 |
| MounjaroTirzepatide | 98 | $106,640 |
| OzempicSemaglutide | 78 | $74,437 |
| JardianceEmpagliflozin | 95 | $70,574 |
| JanuviaSitagliptin Phosphate | 89 | $63,139 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 60 | $44,581 |
| LinzessLinaclotide | 66 | $42,467 |
| FarxigaDapagliflozin Propanediol | 58 | $39,372 |
| TrulicityDulaglutide | 34 | $38,759 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 21 | $30,418 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 35 | $22,880 |
| RybelsusSemaglutide | 24 | $22,332 |
| EntrestoSacubitril/Valsartan | 34 | $22,172 |
| MyrbetriqMirabegron | 17 | $19,032 |
| Tresiba Flextouch U-100Insulin Degludec | 23 | $12,277 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $385 | $145,399132 claims |
| PfizerEliquis | $332 | $132,908164 claims |
| Novo NordiskOzempic, Rybelsus | $234 | $96,769102 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $15 | $82,049113 claims |
| MerckJanuvia | $47 | $63,13989 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $110 | $62,25293 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $99 | $54,19084 claims |
| AbbVieLinzess, Synthroid | $525 | $44,638107 claims |
| NovartisEntresto | $82 | $22,17234 claims |
| Astellas Pharma US IncMyrbetriq | $95 | $19,03217 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $21 | $6,58612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,559 family medicine providers in Kentucky.
Other family medicine in Hodgenville
- Brian SmithVersailles$7.7M
- Barbara Fleming-PhillipsLexington$1.4M
- Christopher RhyneLouisville$1M
- Kruti PatelBurlington$463K
- Michael LovelaceLouisville$244K
- John RichardLexington$226K
- Diego MastronardiBowling Green$196K
- James TurnboPaducah$124K
- Eleida Tur OlivaLexington$113K
- Jeffrey GreenParis$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.